original ) (raw )Inhibition of DNA topoisomerases I and II and growth inhibition of HL-60 cells by novel acridine-based compounds
Jana Janockova , Peter Fedoročko , Slavka Hamulakova
European Journal of Pharmaceutical Sciences, 2015
View PDFchevron_right
Fluorinated 3,6,9-trisubstituted acridine derivatives as DNA interacting agents and topoisomerase inhibitors with A549 antiproliferative activity
Maria Kozurkova
Bioorganic Chemistry, 2019
View PDFchevron_right
Computer Aided Design, Synthesis and Biological Evaluation of Novel Acridine Derivatives a Topoisomerase I Inhibitors
Nasser Ismail
View PDFchevron_right
Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II
Harneet Kaur
European Journal of Pharmacology, 2009
View PDFchevron_right
Molecular Docking studies and in-silico ADMET Screening of Some novel Oxazine substituted 9-Anilinoacridines as Topoisomerase II Inhibitors
Dr. Kalirajan Rajagopal
Indian Journal of Pharmaceutical Education and Research, 2017
View PDFchevron_right
Novel 9-(2-(1-arylethylidene)hydrazinyl)acridine derivatives: Target Topoisomerase 1 and growth inhibition of HeLa cancer cells
Neeraj Kumar Fuloria
Bioorganic Chemistry, 2019
View PDFchevron_right
Synthesis and evaluation of acridine- and acridone-based anti-herpes agents with topoisomerase activity
David Ferguson
2006
View PDFchevron_right
A review of published data on acridine derivatives with different biological activities
Mara Aleksić
Kragujevac Journal of Science
View PDFchevron_right
Acridinecarboxamide topoisomerase poisons: structural and kinetic studies of the DNA complexes of 5-substituted 9-amino-(N-(2-dimethylamino)ethyl)acridine-4-carboxamides
Laurence Wakelin
Molecular pharmacology, 2000
View PDFchevron_right
Antitumor Polycyclic Acridines. 7. 1 Synthesis and Biological Properties of DNA Affinic Tetra-and Pentacyclic Acridines
Johnson Stanslas
Journal of medicinal …, 2000
View PDFchevron_right
Synthesis, DNA-Binding and Antiproliferative Properties of Acridine and 5-Methylacridine Derivatives
Ramon Eritja
2012
View PDFchevron_right
Tacrine derivatives as dual topoisomerase I and II catalytic inhibitors
Jana Janockova , Peter Fedoročko , Slavka Hamulakova
Bioorganic Chemistry, 2015
View PDFchevron_right
Assessment of DNA Topoisomerase I Unwinding Activity, Radical Scavenging Capacity, and Inhibition of Breast Cancer Cell Viability of N-alkyl-acridones and N,N′-dialkyl-9,9′-biacridylidenes
kyriakos papadopoulos
Biomolecules
View PDFchevron_right
Molecular docking analysis of α-Topoisomerase II with δ-Carboline derivatives as potential anticancer agents
vyshnavi tallapaneni
2021
View PDFchevron_right
On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents
David Ferguson
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
New spiro tria(thia)zolidine⿿acridines as topoisomerase inhibitors, DNA binders and cytostatic compounds
Maria Kozurkova
International Journal of Biological Macromolecules, 2016
View PDFchevron_right
Docking studies, synthesis, characterization of some novel oxazine substituted 9-anilinoacridine derivatives and evaluation for their antioxidant and anticancer activities as topoisomerase II inhibitors
Dr. Kalirajan Rajagopal
European Journal of Medicinal Chemistry, 2012
View PDFchevron_right
Chemotherapeutic potential of 9-phenyl acridine: biophysical studies on its binding to DNA
Angshuman Bagchi
European Biophysics Journal With Biophysics Letters, 2010
View PDFchevron_right
Inhibition of DNA Topoisomerase Type IIí µí»¼ (TOP2A) by Mitoxantrone and Its Halogenated Derivatives: A Combined Density Functional and Molecular Docking Study
Mohammad Mazharol Hoque
View PDFchevron_right
Amino- and glycoconjugates of pyrido[4,3,2-kl]acridine. Synthesis, antitumor activity, and DNA binding
Pascal Dumy , Olivier Renaudet
Bioorganic & Medicinal Chemistry, 2006
View PDFchevron_right
Crystal structure of 9-amino-N-[2-(4-morpholinyl)ethyl]-4-acridinecarboxamide bound to d(CGTACG)2: implications for structure-activity relationships of acridinecarboxamide topoisomerase poisons
Laurence Wakelin
Nucleic Acids Research, 2002
View PDFchevron_right
Synthesis and biological evaluation of C1-O-substituted-3-(3-butylamino-2-hydroxy-propoxy)-xanthen-9-one as topoisomerase IIα catalytic inhibitors
Kyu-Yeon Jun
European journal of medicinal chemistry, 2016
View PDFchevron_right
Crystal Structure of the Topoisomerase II Poison 9-Amino-[ N -(2-dimethylamino)ethyl]acridine-4-carboxamide Bound to the DNA Hexanucleotide d(CGTACG) 2 †
Laurence Wakelin
Biochemistry, 1999
View PDFchevron_right
B-Ring-Aryl Substituted Luotonin A Analogues with a New Binding Mode to the Topoisomerase 1-DNA Complex Show Enhanced Cytotoxic Activity
Ana Olives
PLoS ONE, 2014
View PDFchevron_right
Dihydroxylated 2,6-diphenyl-4-chlorophenylpyridines: Topoisomerase I and IIα dual inhibitors with DNA non-intercalative catalytic activity
ganesh bist
European journal of medicinal chemistry, 2017
View PDFchevron_right
SYNTHESIS, CHARACTERIZATION, AND ANTICANCER ACTIVITY OF SOME NOVEL ACRIDINE DERIVATIVES
Asian Journal of Pharmaceutical and Clinical Research Journal
Asian Journal of Pharmaceutical and Clinical Research, 2020
View PDFchevron_right